I hate to be accusatory and usually leave that to Risk since he enjoys taking on the bashers so much. I'll give you the benefit of the doubt for now, but the "MANF is a gem but Lympro is a bust" sentiment is the textbook soft basher approach to buy more cheap shares in the short term. That's all I'm saying. Perhaps that is your honest opinion. If so, I hope you are wrong about Lympro. I'm optimistic based on the information I've seen and heard to this point. Only time will tell and that time is nearing.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links